Skip to search formSkip to main contentSkip to account menu

NVP-QAW039

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

fevipiprant

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma.
Further optimization of an initial DP2 receptor antagonist clinical candidate NVP-QAV680 led to the discovery of a follow-up… 
2017
2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma".
[This corrects the article DOI: 10.1021/acsmedchemlett.7b00157.]. 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)